Lupus carries high risk of all-cause mortality in the young

Study also shows a survival benefit of low-dose hydroxychloroquine

Adults younger than 40 with systemic lupus erythematosus (SLE) have nearly five times the risk of mortality compared with peers who don’t have the condition, a study shows.